Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
11.11.21
OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
11.04.21
OpGen Announces Special Meeting of Stockholders to Vote on Proposed Increase to Number of Authorized Shares of Common Stock
11.04.21
OpGen Appoints Albert Weber as Chief Financial Officer

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events